VNDA
Vanda Pharmaceuticals Inc
Price:  
5.02 
USD
Volume:  
703,151.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VNDA Relative Valuation

-273.5%
Upside

As of 2025-07-10, the Relative Valuation of Vanda Pharmaceuticals Inc (VNDA) is (8.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.02 USD, the upside of Vanda Pharmaceuticals Inc based on Relative Valuation is -273.5%.

The range of the Relative Valuation is (9.28) - (8.82) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 9.3x - 11.7x 9.4x
Forward P/E multiples 12.4x - 17.5x 13.8x
Fair Price (9.28) - (8.82) (8.71)
Upside -284.9% - -275.6% -273.5%
5.02 USD
Stock Price
(8.71) USD
Fair Price

VNDA Relative Valuation - Historical P/E Data

Date P/E
2025-07-08 -6.47
2025-07-07 -6.51
2025-07-03 -6.62
2025-07-02 -6.51
2025-07-01 -6.23
2025-06-30 -6.29
2025-06-27 -6.37
2025-06-26 -6.42
2025-06-25 -6.14
2025-06-24 -5.99
2025-06-23 -5.95
2025-06-20 -6.01
2025-06-18 -6.03
2025-06-17 -5.98
2025-06-16 -6.10
2025-06-13 -6.01
2025-06-12 -6.17
2025-06-11 -6.10
2025-06-10 -6.21
2025-06-09 -6.11
2025-06-06 -6.14
2025-06-05 -5.85
2025-06-04 -5.91
2025-06-03 -5.85
2025-06-02 -5.73
2025-05-30 -5.78
2025-05-29 -5.85
2025-05-28 -5.74
2025-05-27 -5.77
2025-05-23 -5.77
2025-05-22 -5.65
2025-05-21 -5.75
2025-05-20 -5.91
2025-05-19 -5.74
2025-05-16 -5.54
2025-05-15 -5.23
2025-05-14 -5.22
2025-05-13 -5.30
2025-05-12 -5.37
2025-05-09 -5.26
2025-05-08 -5.62
2025-05-07 -5.83
2025-05-06 -5.82
2025-05-05 -6.11
2025-05-02 -6.09
2025-05-01 -5.91
2025-04-30 -6.01
2025-04-29 -5.90
2025-04-28 -5.73
2025-04-25 -5.66